obese mice (MedChemExpress)
Structured Review

Obese Mice, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 56 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/obese+mice/Olcegepant/pmc13683677-72-2-18
Average 95 stars, based on 56 article reviews
Images
1) Product Images from "Neuroimmune activation of the TRPV1–RAMP1 axis drives type 2 immunity to repair intestinal barrier and alleviate metabolic disease"
Article Title: Neuroimmune activation of the TRPV1–RAMP1 axis drives type 2 immunity to repair intestinal barrier and alleviate metabolic disease
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2026.1965520
Figure Legend Snippet: Electroacupuncture mediates activation of intestinal type 2 immunity in a RAMP1-dependent manner. (A) Representative immunofluorescence images of DAPI (blue), ST2 (green), CD90 (red), and RAMP1 (purple) in the proximal colon of ND, HFD, HFD + EA and HFD + Sham groups. (B) Percentage of RAMP1-positive ILC2s in the proximal colon of ND, HFD, HFD + EA and HFD + Sham groups. (C) Representative immunofluorescence images of DAPI (blue), ST2 (green), CD90 (red), and RAMP1 (purple) in the distal colon of ND, HFD, HFD + EA and HFD + Sham groups. (D) Percentage of RAMP1-positive ILC2s in the distal colon of ND, HFD, HFD + EA and HFD + Sham groups. (E, F) Representative flow cytometry plots and quantification of ILC2s in the proximal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (G) Representative immunofluorescence images of DAPI (blue), ST2 (green), and CD90 (red) in the proximal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (H) Percentage of ILC2s in the proximal colon of Ctrl, BIBN4096, and BIBN4096+EA groups. (I–K) Western blot analysis and quantification of IL-5 and IL-13 protein levels in the proximal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (L) Representative H&E staining images of the proximal colon in Ctrl, BIBN4096, and BIBN4096+EA groups. (M, N) Representative AB-PAS staining images and quantification of goblet cell ratio in the proximal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (O, P) Representative flow cytometry plots and quantification of ILC2s in the distal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (Q) Representative immunofluorescence images of DAPI (blue), ST2 (green), and CD90 (red) in the distal colon of Ctrl, BIBN4096, and BIBN4096+EA groups. (R) Percentage of ILC2s in the distal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (S–U) Western blot analysis and quantification of IL-5 and IL-13 protein levels in the distal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (V) Representative H&E staining images of the distal colon in HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (W, X) Representative AB-PAS staining images and quantification of goblet cell ratio in the distal colon of HFD + Vehicle, BIBN4096, and BIBN4096+EA groups. (Y) Representative immunofluorescence images of DAPI (blue), ST2 (green), and CD90 (red) in the proximal colon of solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Z) Percentage of ILC2s in the proximal colon of solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Aa–Cc) Western blot analysis and quantification of IL-5 and IL-13 protein levels in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Dd) Relative il-5 mRNA expression in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37 +EA groups. (Ee) Relative IL-5 expression in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Ff) Relative il-13 mRNA expression in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Gg) Relative IL-13 expression in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37 +EA groups. (Hh) Representative H&E staining images of the proximal colon in Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Jj–Ll) Representative AB-PAS staining images and quantification of goblet cell ratio in the proximal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Kk) Representative immunofluorescence images of DAPI (blue), ST2 (green), and CD90 (red) in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Ll) Percentage of ILC2s in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Mm–Oo) Western blot analysis and quantification of IL-5 and IL-13 protein levels in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Pp) Relative il-5 mRNA expression in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Qq) Relative IL-5 expression in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Rr) Relative il-13 mRNA expression in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Ss) Relative IL-13 expression in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Tt) Representative H&E staining images of the distal colon in Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (Uu, Vv) Representative AB-PAS staining images and quantification of goblet cell ratio in the distal colon of Solvent, CGRP 8-37, and CGRP 8-37+EA groups. (A–D, G–N, Q, R, V–Z, Dd–Ll, Pp–Vv) n=5. (E, F, I–K, O, P, S–U, Aa–Cc, Mm–Oo) n=4. (A, C, G, Q, Y, Kk) Scale bar = 100 µm; (L, M, V, W, Hh, li, Tt, Uu) Scale bar = 200 µm. Error bars represent mean ± SEM. Data were analyzed by one-way ANOVA (Tukey’s HSD post hoc test). ns indicates no significant difference; *p < 0.05.
Techniques Used: Activation Assay, Immunofluorescence, Flow Cytometry, Western Blot, Analysis, Staining, Solvent, Expressing
Related Articles
Saline:Article Title: Intermittent fasting attenuates ovarian chronic inflammation in obese mice by inhibiting the CXCL12-CXCR4 axis. Article Snippet: Aim: Obesity disrupts ovarian function in female via chronic inflammation.. Intermittent fasting (IF) prevents obesity and exerts protective effects against inflammation.. However, the underlying mechanisms remain poorly understood. Article Title: Neuroimmune activation of the TRPV1–RAMP1 axis drives type 2 immunity to repair intestinal barrier and alleviate metabolic disease Article Snippet: .. Successfully modeled Injection:Article Title: Neuroimmune activation of the TRPV1–RAMP1 axis drives type 2 immunity to repair intestinal barrier and alleviate metabolic disease Article Snippet: .. Successfully modeled |


